Delivery of viral vectors to tumor cells: extracellular transport, systemic distribution, and strategies for improvement

Annals of Biomedical Engineering
Yong Wang, Fan Yuan

Abstract

It is a challenge to deliver therapeutic genes to tumor cells using viral vectors because (i) the size of these vectors are close to or larger than the space between fibers in extracellular matrix and (ii) viral proteins are potentially toxic in normal tissues. In general, gene delivery is hindered by various physiological barriers to virus transport from the site of injection to the nucleus of tumor cells and is limited by normal tissue tolerance of toxicity determined by local concentrations of transgene products and viral proteins. To illustrate the obstacles encountered in the delivery and yet limit the scope of discussion, this review focuses only on extracellular transport in solid tumors and distribution of viral vectors in normal organs after they are injected intravenously or intratumorally. This review also discusses current strategies for improving intratumoral transport and specificity of viral vectors.

References

Jun 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·M Gossen, H Bujard
Nov 1, 1992·The American Review of Respiratory Disease·E M Renkin
Jan 1, 1990·Human Gene Therapy·K CornettaW F Anderson
Sep 28, 1990·Science·R Langer
Jul 1, 1983·Journal of Surgical Oncology·Y T Lee
Nov 1, 1995·American Journal of Respiratory Cell and Molecular Biology·B J PetrofG Karpati
Aug 1, 1995·Nature Medicine·D E HallahanR R Weichselbaum
Apr 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M HarrisonS Stewart
Jan 1, 1994·Acta Oncologica·A GabizonT Peretz
Mar 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·R H BoboE H Oldfield
Feb 1, 1993·Seminars in Liver Disease·Y ShiratoriM Omata
Apr 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·J Herz, R D Gerard
Nov 1, 1995·Journal of Neuro-oncology·M MakW M Saltzman
Jan 1, 1997·Journal of the National Cancer Institute·J A Roth, R J Cristiano
May 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E S CasperM F Brennan
Jul 22, 1997·Proceedings of the National Academy of Sciences of the United States of America·G JensterB W O'Malley
Sep 26, 1997·Nature·I M Verma, N Somia
Feb 24, 1998·Gene Therapy·B E RogersD T Curiel
Mar 5, 1998·Journal of the National Cancer Institute·H L Kong, R G Crystal
May 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·S K HobbsR K Jain
Jun 20, 1998·Seminars in Radiation Oncology·M W Dewhirst
Jun 20, 1998·Seminars in Radiation Oncology·F Yuan
Nov 1, 1996·Nature Biotechnology·J T DouglasD T Curiel
Jul 8, 1998·Progress in Neurobiology·W T Hermens, J Verhaagen
Aug 7, 1998·Human Gene Therapy·D SchellingerhoutR Weissleder
Oct 14, 1998·Cancer Metastasis Reviews·C Blancher, A L Harris
Mar 17, 1999·Cancer Gene Therapy·Y LuM S Steiner

❮ Previous
Next ❯

Citations

Apr 22, 2008·Annals of Biomedical Engineering·Jill M StukelMichael R Caplan
Feb 9, 2010·Annals of Biomedical Engineering·Cheng-Wen Lin, Fan Yuan
Oct 13, 2007·Pharmaceutical Research·Sean M HartigJeffrey M Davidson
Nov 28, 2007·Biomacromolecules·Elena V RoscaMichael R Caplan
Sep 22, 2012·Proceedings of the National Academy of Sciences of the United States of America·Jieqiong LiuLei Xu
Dec 25, 2009·Human Gene Therapy·Norman MaitlandUNKNOWN GIANT FP6 Consortium
Apr 23, 2008·Molecular Pharmacology·Vidula Dixit, Rudy L Juliano
Apr 27, 2007·Annual Review of Biomedical Engineering·Melody A Swartz, Mark E Fleury
Aug 30, 2008·Molecular Cancer Therapeutics·Joshua HenshawFan Yuan
Sep 24, 2011·Virology Journal·Motoko ShintaniYoshiaki Yura
Jan 1, 2013·Journal of Therapeutic Ultrasound·Ahmad AlassafVictor Frenkel
Dec 25, 2007·Experimental Biology and Medicine·David A ZaharoffFan Yuan
Mar 8, 2013·The Journal of the Acoustical Society of America·Ali ZiadlooVictor Frenkel
Jun 23, 2009·Expert Opinion on Drug Delivery·Jill M Stukel, Michael R Caplan
Jun 10, 2010·Journal of Pharmaceutical Sciences·Nelita T Elliott, Fan Yuan
Sep 12, 2007·Journal of Pharmaceutical Sciences·Brent D WeinbergJinming Gao
Jan 18, 2012·Nanomedicine : Nanotechnology, Biology, and Medicine·Sarah McGuire, Fan Yuan
Mar 2, 2010·The Journal of Surgical Research·Zhenggang ChenFengcai Wei
Jun 23, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·I-Chien LiaoKam W Leong
Oct 3, 2008·Biotechnology Journal·Zhijun WangLi Jin
Nov 30, 2011·Biotechnology and Bioengineering·Nelita T Elliott, Fan Yuan
Jul 9, 2008·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Brian E O'Neill, King C P Li
Dec 17, 2010·Analytical and Bioanalytical Chemistry·Boonchoy Soontornworajit, Yong Wang
Jun 1, 2017·Frontiers in Pharmacology·Dhaval S SanchalaKedar S Prabhavalkar
Mar 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Peter C HuszthyRolf Bjerkvig
Oct 19, 2019·Journal of Theoretical Biology·Adrianne L JennerPeter S Kim
Jan 7, 2018·Trends in Biotechnology·Zachary GlassQiaobing Xu
Jun 29, 2021·Advanced Drug Delivery Reviews·Sofie SnipstadCatharina de Lange Davies

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.